Zobrazeno 1 - 10
of 54
pro vyhledávání: '"BJ Eastwood"'
Publikováno v:
Canadian Journal of Gastroenterology, Vol 10, Iss 6, Pp 369-375 (1996)
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, but there are discrepancies in the reported incidence and associated risk factors. This retrospective study describes 104 Nova Scotian patients with ps
Externí odkaz:
https://doaj.org/article/7b6ada2f977a452b81cdd61c007f23f8
Publikováno v:
Journal of Solid State Electrochemistry. 3:179-186
The suitability of a polymeric composite material for use as part of an anode structure in a cathodic protection system has been examined. The composite material was a conductive blend (volume resistivity typically 1.5 Ω cm) of carbon black in a pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d5e8495fe09d1799e4cbeb69a7af27c
https://doi.org/10.1007/s100080050145
https://doi.org/10.1007/s100080050145
Publikováno v:
Canadian Journal of Gastroenterology, Vol 10, Iss 6, Pp 369-375 (1996)
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, but there are discrepancies in the reported incidence and associated risk factors. This retrospective study describes 104 Nova Scotian patients with ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12bea1a3d7f02ec7cbb7da61164c7d4f
https://pubmed.ncbi.nlm.nih.gov/9193771
https://pubmed.ncbi.nlm.nih.gov/9193771
Autor:
Hosseini-Gerami L; Centre for Molecular Informatics, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; AbsoluteAi Ltd, London, UK., Ficulle E; Eli Lilly and Company, Windlesham, UK.; Zifo RnD Solutions, London, UK., Humphryes-Kirilov N; Eli Lilly and Company, Windlesham, UK.; C4X Discovery, Manchester, UK., Airey DC; Eli Lilly and Company, Corporate Centre, Indianapolis, IN, USA., Scherschel J; Eli Lilly and Company, Corporate Centre, Indianapolis, IN, USA., Kananathan S; Eli Lilly and Company, Windlesham, UK.; Eli Lilly and Company, Bracknell, UK., Eastwood BJ; Eli Lilly and Company, Windlesham, UK.; Eli Lilly and Company, Bracknell, UK.; Eli Lilly and Company (Retired), Bracknell, UK., Bose S; Eli Lilly and Company, Windlesham, UK.; Eli Lilly and Company, Bracknell, UK., Collier DA; Eli Lilly and Company, Windlesham, UK.; Eli Lilly and Company, Bracknell, UK.; Social, Genetic and Developmental Psychiatry Centre, IoPPN, Kings's College London and Genetic and Genomic Consulting Ltd, Farnham, UK., Laing E; Eli Lilly and Company, Windlesham, UK.; GSK, Stevenage, UK., Evans D; Eli Lilly and Company, Windlesham, UK.; DeepMind, London, UK., Broughton H; Eli Lilly and Company, Centro de Inovación, Alcobendas, Spain., Bender A; Centre for Molecular Informatics, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. ab454@cam.ac.uk.
Publikováno v:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Mar 14; Vol. 15 (1), pp. 52. Date of Electronic Publication: 2023 Mar 14.
Autor:
McCarthy AP; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.) mccarthy_andrew_peter@lilly.com., Svensson KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Shanks E; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Brittain C; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Eastwood BJ; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Kielbasa W; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Biglan KM; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Wafford KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Mar; Vol. 380 (3), pp. 143-152. Date of Electronic Publication: 2021 Dec 10.
Autor:
Ficulle E; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; UK Dementia Research Institute, UCL, London, WC1E 6BT, UK., Kananathan S; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; Eli Lilly & Company, 8 Arlington Square West, Bracknell, RG12 1PU, UK., Airey D; Eli Lilly & Company, Indianapolis, IN, USA., Gharbi SI; Eli Lilly & Company, Alcobendas, Spain., Humphryes-Kirilov N; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; C4X Discovery Ltd, London, NW1 1AD, UK., Scherschel J; Eli Lilly & Company, Indianapolis, IN, USA., Dunbar C; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; Eli Lilly & Company, 8 Arlington Square West, Bracknell, RG12 1PU, UK., Eastwood BJ; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; Eli Lilly & Company, 8 Arlington Square West, Bracknell, RG12 1PU, UK., Laing E; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK.; GSK, Gunnels Wood Rd, Stevenage, SG1 2NY, UK., Collier DA; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK. collier_david_andrew@lilly.com.; Eli Lilly & Company, 8 Arlington Square West, Bracknell, RG12 1PU, UK. collier_david_andrew@lilly.com., Bose S; Eli Lilly & Company, Erl Wood Manor, Sunninghill Road, Windlesham, GU20 6PH, Surrey, UK. bose_suchira@lilly.com.; Eli Lilly & Company, 8 Arlington Square West, Bracknell, RG12 1PU, UK. bose_suchira@lilly.com.
Publikováno v:
Scientific reports [Sci Rep] 2022 Feb 17; Vol. 12 (1), pp. 2673. Date of Electronic Publication: 2022 Feb 17.
Autor:
Katsikoudi A; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Ficulle E; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Cavallini A; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Sharman G; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Guyot A; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Zagnoni M; Centre for Microsystems & Photonics, Department of Electronic and Electrical Engineering, University of Strathclyde, Glasgow, United Kingdom., Eastwood BJ; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Hutton M; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom., Bose S; Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom. Electronic address: bose_suchira@lilly.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Sep 11; Vol. 295 (37), pp. 13079-13093. Date of Electronic Publication: 2020 Jul 22.
Autor:
Holton CM; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Hanley N; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Shanks E; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Oxley P; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., McCarthy A; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Eastwood BJ; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Murray TK; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Nickerson A; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Wafford KA; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK. kwafford@slowavetx.co.uk.
Publikováno v:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Jul 15; Vol. 12 (1), pp. 84. Date of Electronic Publication: 2020 Jul 15.
Autor:
Li Y; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Higgs RE; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Hoffman RW; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Dow ER; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Liu X; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Petri M; Hopkins Lupus Center, John Hopkins University, Baltimore, Maryland, United States of America., Wallace DJ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Dörner T; Charité University Hospitals, Berlin, Germany., Eastwood BJ; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Miller BB; Eli Lilly and Company, Indianapolis, Indiana, United States of America., Liu Y; Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Publikováno v:
PloS one [PLoS One] 2019 Dec 02; Vol. 14 (12), pp. e0225651. Date of Electronic Publication: 2019 Dec 02 (Print Publication: 2019).
Autor:
Wilenkin B; Department of Quantitative Biology, Eli Lilly and Company, Indianapolis, Indiana., Burris KD; Department of Quantitative Biology, Eli Lilly and Company, Indianapolis, Indiana., Eastwood BJ; Department of Statistics, Eli Lilly and Company, Indianapolis, Indiana., Sher E; Department of Discovery Pain Group, Eli Lilly and Company, Indianapolis, Indiana., Williams AC; Department of Medicinal Chemistry, Eli Lilly and Company, Indianapolis, Indiana., Priest BT; Department of Quantitative Biology, Eli Lilly and Company, Indianapolis, Indiana.
Publikováno v:
Assay and drug development technologies [Assay Drug Dev Technol] 2019 Oct; Vol. 17 (7), pp. 310-321.